Evidence map›Paper›PMID 35733216›Full record

ArticleJournal of nanobiotechnology2022

Fucoidan with three functions extracted from Sargassum aquifolium integrated rice-husk synthesis dual-imaging mesoporous silica nanoparticle.

Zui-Harng Lee, Meng-Feng Lee, Jung-Huang Chen, Min-Hsuan Tsou, Zhi-Yuan Wu, Cheng-Zhang Lee, Yu-Ya Huang, Showe-Mei Lin, Hsiu-Mei Lin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Zui-Harng LeeDepartment of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, 202, Taiwan.
Meng-Feng LeeDepartment of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, 202, Taiwan.
Jung-Huang ChenDepartment of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, 202, Taiwan.
Min-Hsuan TsouDepartment of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, 202, Taiwan.
Zhi-Yuan WuDepartment of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, 202, Taiwan.
Cheng-Zhang LeeDepartment of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, 202, Taiwan.
Yu-Ya HuangDepartment of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, 202, Taiwan.
Showe-Mei LinInstitute of Marine Biology, National Taiwan Ocean University, Keelung, 202, Taiwan.
Hsiu-Mei LinDepartment of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, 202, Taiwan. hmlin@mail.ntou.edu.tw.
National Taiwan Ocean University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we used the nanoparticle delivery system to reduce the side effect of conventional cancer treatment- radiation therapy and chemotherapy. We used rice husk silicon source mesoporous silica nanoparticle doped in Eu

Indexed as

NanoparticlesNeoplasmsOryzaSargassumHumansPolysaccharidesSilicon DioxidefucoidanPolysaccharidesSilicon DioxideAnticancerDual-imagingFucoidanMesoporous silica nanoparticlesRice huskSargassum aquifoliumTarget therapy

Identifiers

PMID35733216
PMCPMC9215008
OpenAlexW4283278679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.